Life Sciences

We know healthcare. The breadth and depth of our expertise is exceptional and informed by outstanding performance for a broad array of Fortune 500 companies since 2000. Our content is objective, driven by unique data assets, and unfailingly creative. Check us out.

Why Work with Us

Optimize Patient Access

For over 20 years, pharma, device manufacturers, industry associations and foundations, patient groups, and the US government have relied on our expertise to adapt to our ever-changing, complex industry. We understand firsthand what it takes to compete because we come directly from industry. Our deep market knowledge and data-driven analyses drive practical solutions to keep you ahead. Every day, we work alongside colleagues who come from providers, plans, associations, foundations, patient advocacy groups, and regulators to gain a comprehensive viewpoint from each industry stakeholder. Explore our full suite of customized services that are flexible for a single engagement or a multi-year partnership. Rest assured, we are with you every step of the way. Together, we can move healthcare forward by improving patients’ lives and meeting the bottom line.

The top 25 global biopharmaceutical companies count on us to help them navigate today’s healthcare environment.

Life Sciences Capabilities

Our Experts

Lance Grady

Lance Grady

Executive Vice President, Life Sciences Strategy & Growth

Lance Grady is the head of Avalere’s Life Sciences Strategy & Growth.

Milena Sullivan

Milena Sullivan

Managing Director, Policy

Milena Sullivan advises life sciences clients on the impact of the evolving healthcare policy landscape on their commercial, access, and advocacy priorities.

Omar Hafez

Omar Hafez

Practice Director, Market Access & Reimbursement

Omar Hafez advises a range of clients on issues including supply chain, drug pricing, launch strategy, and oncology market analytics and planning. He brings deep expertise working on strategy, operations, commercialization, and analytics across core client segments.

Back To Top